{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:46:12Z","timestamp":1791179172378,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Oral Cancer Overexpressed 1 (ORAOV1) is a candidate protooncogene locating on 11q13. Recent studies show that ORAOV1 acts as a primary driving force behind 11q13 gene amplification and plays a functional role in the tumorigenesis in a variety of human squamous cell carcinomas (SCCs). According to the results of molecular cytogenetic methods, 11q13 was characterized to be a high-level and recurrent amplification chromosomal site in cervical cancers. Up till now, the role of ORAOV1 in cervical cancer is unknown. The purpose of this study is to elucidate the function of ORAOV1 in cervical cancer cell growth by studying its roles in HeLa cells using small interfering RNA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Functional analyses revealed that ORAOV1 was involved in the regulation of HeLa cell growth through its effect on cell cycle and apoptosis. Silence of ORAOV1 in HeLa cells downregulated the expression of Cyclin A, Cyclin B1 and Cdc2, and led to a distinct S cell cycle arrest. Moreover, knockdown of ORAOV1 expression activated both extrinsic and intrinsic apoptotic pathways and led to apoptosis in HeLa cells through its effect on the expression of several apoptosis related proteins such as P53, Bcl-2, Caspase-3, Caspase-8, Caspase-9 and cytochrome c. Interestingly, the expression of Cyclin D1, a pivotal gene for cervical cancer tumorigenesis, was also found to be reduced in ORAOV1 silenced HeLa cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings indicate that ORAOV1 has an important role in regulating cell growth of cervical cancer HeLa cells through regulating the cell cycle and apoptosis. Thus, it may be a crucial protooncogene and a novel candidate therapeutic target for cervical cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-9-20","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T07:14:53Z","timestamp":1264662893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells"],"prefix":"10.1186","volume":"9","author":[{"given":"Lu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,28]]},"reference":[{"key":"535_CR1","doi-asserted-by":"publisher","first-page":"11369","DOI":"10.1073\/pnas.172285799","volume":"99","author":"X Huang","year":"2002","unstructured":"Huang X, Gollin SM, Raja S, Godfrey TE: High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci. 2002, 99: 11369-11374. 10.1073\/pnas.172285799","journal-title":"Proc Natl Acad Sci"},{"key":"535_CR2","first-page":"2029","volume":"26","author":"Y Komatsu","year":"2006","unstructured":"Komatsu Y, Hibi K, Kodera Y, Akiyama S, Ito K, Nakao A: TAOS1, a novel marker for advanced esophageal squamous cell carcinoma. Anticancer Res. 2006, 26: 2029-2032.","journal-title":"Anticancer Res"},{"key":"535_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.oraloncology.2006.05.008","volume":"43","author":"J Xia","year":"2007","unstructured":"Xia J, Chen Q, Li B, Zeng X: Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features. Oral Oncol. 2007, 43: 508-514. 10.1016\/j.oraloncology.2006.05.008","journal-title":"Oral Oncol"},{"key":"535_CR4","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/ijc.23734","volume":"123","author":"L Jiang","year":"2008","unstructured":"Jiang L, Zeng X, Yang H, Wang Z, Shen J, Bai J, Zhang Y, Gao F, Zhou M, Chen Q: Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma. Int J Cancer. 2008, 123: 1779-1786. 10.1002\/ijc.23734","journal-title":"Int J Cancer"},{"key":"535_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0964-1955(94)90062-0","volume":"30","author":"D Muller","year":"1994","unstructured":"Muller D, Millon R, Lidereau R, Engelmann A, Bronner G, Flesch H, Eber M, Methlin G, Abecassis J: Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer B Oral Oncol. 1994, 30: 113-120. 10.1016\/0964-1955(94)90062-0.","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"535_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0964-1955(92)90016-T","volume":"28","author":"JK Field","year":"1992","unstructured":"Field JK: Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol. 1992, 28: 67-76. 10.1016\/0964-1955(92)90016-T.","journal-title":"Eur J Cancer B Oral Oncol"},{"issue":"32","key":"535_CR7","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/onc.2009.150","volume":"28","author":"A Baras","year":"2009","unstructured":"Baras A, Yu Y, Filtz M, Kim B, Moskaluk CA: Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification. Oncogene. 2009, 28 (32): 2919-2. 10.1038\/onc.2009.150","journal-title":"Oncogene"},{"key":"535_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1525-1438.2007.00834.x","volume":"17","author":"YW Choi","year":"2007","unstructured":"Choi YW, Bae SM, Kim YW, Lee HN, Kim YW, Park TC, Ro DY, Shin JC, Shin SJ, Seo JS, Ahn WS: Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer. 2007, 17: 687-696. 10.1111\/j.1525-1438.2007.00834.x","journal-title":"Int J Gynecol Cancer"},{"key":"535_CR9","first-page":"141","volume":"59","author":"M Macville","year":"1999","unstructured":"Macville M, Schr\u00f6ck E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, Popescu N, Ried T: Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 1999, 59: 141-150.","journal-title":"Cancer Res"},{"key":"535_CR10","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1073\/pnas.032652399","volume":"99","author":"PJ Paddison","year":"2002","unstructured":"Paddison PJ, Caudy AA, Hannon GJ: Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci. 2002, 99: 1443-1448. 10.1073\/pnas.032652399","journal-title":"Proc Natl Acad Sci"},{"key":"535_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1677\/jme.1.01582","volume":"33","author":"I Bantounas","year":"2004","unstructured":"Bantounas I, Phylactou LA, Uney JB: RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J Mol Endocrinol. 2004, 33: 545-557. 10.1677\/jme.1.01582","journal-title":"J Mol Endocrinol"},{"key":"535_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S: A Review of Programmed Cell Death. Toxicol Pathol. 2007, 35: 495-516. 10.1080\/01926230701320337","journal-title":"Toxicol Pathol"},{"key":"535_CR13","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1101\/gad.1126903","volume":"17","author":"JM Adams","year":"2003","unstructured":"Adams JM: Ways of dying: multiple pathways to apoptosis. Genes & Dev. 2003, 17: 2481","journal-title":"Genes & Dev"},{"key":"535_CR14","first-page":"1017","volume":"164","author":"EL Franco","year":"2001","unstructured":"Franco EL, Duarte-Franco E, Ferenczy A: Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Can Med Assoc J. 2001, 164: 1017-1025.","journal-title":"Can Med Assoc J"},{"key":"535_CR15","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","volume":"17","author":"RP Insinga","year":"2008","unstructured":"Insinga RP, Liaw KL, Johnson LG, Madeleine MM: A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1611-1622. 10.1158\/1055-9965.EPI-07-2922","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"535_CR16","first-page":"193","volume":"30","author":"L Verleye","year":"2009","unstructured":"Verleye L, Thomakos N, Edmondson RJ: Recurrent cervical cancer presenting as malignant pericarditis: case report and review of the literature. Eur J Gynaecol Oncol. 2009, 30: 193-195.","journal-title":"Eur J Gynaecol Oncol"},{"key":"535_CR17","first-page":"705","volume":"56","author":"RA Jesudasan","year":"1995","unstructured":"Jesudasan RA, Rahman RA, Chandrashekharappa S, Evans GA, Srivatsan ES: Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am J Hum Genet. 1995, 56: 705-715.","journal-title":"Am J Hum Genet"},{"key":"535_CR18","first-page":"292","volume":"18","author":"AA Bahnassy","year":"2006","unstructured":"Bahnassy AA, Zekri AR, Alam El-Din HM, Aboubakr AA, Kamel K, El-Sabah MT, Mokhtar NM: The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. J Egypt Natl Canc Inst. 2006, 18: 292-302.","journal-title":"J Egypt Natl Canc Inst"},{"key":"535_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0092-8674(00)80625-X","volume":"101","author":"H Zhang","year":"2000","unstructured":"Zhang H, Gavin M, Dahiya A, Postigo A, Ma D, Luo R, Harbour J, Dean D: Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI\/SNF and Rb-hSWI\/SNF. Cell. 2000, 101: 79-89. 10.1016\/S0092-8674(00)80625-X","journal-title":"Cell"},{"key":"535_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.onc.1208218","volume":"24","author":"S Xie","year":"2005","unstructured":"Xie S, Xie B, Lee MY, Dai W: Regulation of cell cycle checkpoints by polo-like kinases. Oncogene. 2005, 24: 277-286. 10.1038\/sj.onc.1208218","journal-title":"Oncogene"},{"key":"535_CR21","first-page":"3689","volume":"60","author":"CJ Sherr","year":"2000","unstructured":"Sherr CJ: The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000, 60: 3689-3695.","journal-title":"Cancer Res"},{"key":"535_CR22","doi-asserted-by":"publisher","first-page":"6345","DOI":"10.1158\/0008-5472.CAN-05-4460","volume":"66","author":"EJ Yeo","year":"2006","unstructured":"Yeo EJ, Ryu JH, Chun YS, Cho YS, Jang IJ, Cho H, Kim J, Kim MS, Park JW: YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases. Cancer Res. 2006, 66: 6345-6352. 10.1158\/0008-5472.CAN-05-4460","journal-title":"Cancer Res"},{"key":"535_CR23","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1073\/pnas.96.5.2147","volume":"96","author":"SA Innocente","year":"1999","unstructured":"Innocente SA, Abrahamson JL, Cogswell JP, Lee JM: p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci. 1999, 96: 2147-2152. 10.1073\/pnas.96.5.2147","journal-title":"Proc Natl Acad Sci"},{"key":"535_CR24","first-page":"1","volume":"9","author":"C Burz","year":"2009","unstructured":"Burz C, Berindan-Neagoe I, Balacescu O, Irimie A: Apoptosis in cancer: Key molecular signaling pathways and therapy targets. Acta Oncol. 2009, 9: 1-11.","journal-title":"Acta Oncol"},{"key":"535_CR25","doi-asserted-by":"publisher","first-page":"F21","DOI":"10.1084\/jem.192.8.F21","volume":"192","author":"S Roy","year":"2000","unstructured":"Roy S, Nicholson DW: Cross-talk in cell death signaling. J Exp Med. 2000, 192: F21-25. 10.1084\/jem.192.8.F21","journal-title":"J Exp Med"},{"key":"535_CR26","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1242\/jcs.00739","volume":"116","author":"S Haupt","year":"2003","unstructured":"Haupt S, Berger M, Goldberg Z, Haupt Y: Apoptosis - the p53 network. J Cell Sci. 2003, 116: 4077-4085. 10.1242\/jcs.00739","journal-title":"J Cell Sci"},{"key":"535_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1242\/jcs.031682","volume":"122","author":"JK Brunelle","year":"2009","unstructured":"Brunelle JK, Letai A: Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci. 2009, 122: 437-441. 10.1242\/jcs.031682","journal-title":"J Cell Sci"},{"key":"535_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11010-009-0025-5","volume":"325","author":"M Singh","year":"2009","unstructured":"Singh M, Singh N: Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol Cell Biochem. 2009, 325: 107-119. 10.1007\/s11010-009-0025-5","journal-title":"Mol Cell Biochem"},{"key":"535_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<380::AID-CNCR22>3.0.CO;2-W","volume":"79","author":"JA Akervall","year":"1997","unstructured":"Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer. 1997, 79: 380-389. 10.1002\/(SICI)1097-0142(19970115)79:2<380::AID-CNCR22>3.0.CO;2-W","journal-title":"Cancer"},{"key":"535_CR30","first-page":"292","volume":"18","author":"AA Bahnassy","year":"2006","unstructured":"Bahnassy AA, Zekri AR, Alam El-Din HM, Aboubakr AA, Kamel K, El-Sabah MT, Mokhtar NM: The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. J Egypt Natl Canc Inst. 2006, 18: 292-302.","journal-title":"J Egypt Natl Canc Inst"},{"key":"535_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/gyno.2001.6196","volume":"81","author":"DS Bae","year":"2001","unstructured":"Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, Kim DS, Lee JH: Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol. 2001, 81: 341-347. 10.1006\/gyno.2001.6196","journal-title":"Gynecol Oncol"},{"key":"535_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/0022034509336994","volume":"88","author":"L Jiang","year":"2009","unstructured":"Jiang L, Yang HS, Wang Z, Zhou Y, Zhou M, Zeng X, Chen QM: ORAOV1-A correlates with poor differentiation in oral cancer. J Dent Res. 2009, 88: 433-438. 10.1177\/0022034509336994","journal-title":"J Dent Res"},{"key":"535_CR33","doi-asserted-by":"publisher","first-page":"9018","DOI":"10.1128\/MCB.20.23.9018-9027.2000","volume":"20","author":"RA Blake","year":"6656","unstructured":"Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA: SU a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol. 6656, 20: 9018-9027. 10.1128\/MCB.20.23.9018-9027.2000. 10.1128\/MCB.20.23.9018-9027.2000","journal-title":"Mol Cell Biol"},{"key":"535_CR34","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/sj.onc.1203599","volume":"19","author":"J Liu","year":"2000","unstructured":"Liu J, Prolla G, Rostagno A, Chiarle R, Feiner H, Inghirami G: Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DBRCA1 (17aa). Oncogene. 2000, 19: 2767-2773. 10.1038\/sj.onc.1203599","journal-title":"Oncogene"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-9-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:09:58Z","timestamp":1630472998000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-9-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-9-20","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,28]]},"assertion":[{"value":"23 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"20"}}